241 related articles for article (PubMed ID: 7543127)
41. Incidence and pathophysiology of hypercalcemia.
Mundy GR
Calcif Tissue Int; 1990; 46 Suppl():S3-10. PubMed ID: 2105829
[TBL] [Abstract][Full Text] [Related]
42. [Hypercalcemia caused by malignant tumor--emergency treatment].
Abe K
Nihon Rinsho; 1978 May; Suppl():1602-3. PubMed ID: 691447
[No Abstract] [Full Text] [Related]
43. Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis.
Warrell RP; Skelos A; Alcock NW; Bockman RS
Cancer Res; 1986 Aug; 46(8):4208-12. PubMed ID: 3731088
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in pathophysiology and treatment of hypercalcemia of malignancy.
Mundy GR; Yates AJ
Am J Kidney Dis; 1989 Jul; 14(1):2-12. PubMed ID: 2662763
[No Abstract] [Full Text] [Related]
45. [Hypercalcemia: a practical review].
Barbry A; Masserey-Bonvin V; Petignat PA
Rev Med Suisse; 2024 Feb; 20(860):300-304. PubMed ID: 38323765
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of neoplastic hypercalcemia].
Herrero Huerta F; Torralba Saura M; Petrel Serrano L; Palazón Moñino D; Cuesta López F
An Med Interna; 1991 Feb; 8(2):94-7. PubMed ID: 1893011
[TBL] [Abstract][Full Text] [Related]
47. [The practitioner's approach to acute hypercalcemia].
Schaison G
Presse Med (1893); 1969 Jun; 77(30):1083-5. PubMed ID: 4978389
[No Abstract] [Full Text] [Related]
48. [Recent progress in the pathogenesis and treatment of neoplastic hypercalcemia].
Body JJ; Borkowski A
Rev Med Brux; 1985 Feb; 6(2):81-4. PubMed ID: 3157210
[No Abstract] [Full Text] [Related]
49. Cancer-induced hypercalcemia.
Coward DD
Cancer Nurs; 1986 Jun; 9(3):125-32. PubMed ID: 3636175
[No Abstract] [Full Text] [Related]
50. Supportive care.
Markman M
Cancer Chemother Biol Response Modif; 1991; 12():651-9. PubMed ID: 1718380
[No Abstract] [Full Text] [Related]
51. [Hypercalcemia in blood diseases and cancers].
Fouqueray B; Pruna A; Idatte JM
Rev Prat; 1989 Apr; 39(11):937-41. PubMed ID: 2717865
[TBL] [Abstract][Full Text] [Related]
52. Hypercalcemia.
Klee GG; Kao PC; Heath H
Endocrinol Metab Clin North Am; 1988 Sep; 17(3):573-600. PubMed ID: 3065081
[TBL] [Abstract][Full Text] [Related]
53. Rehydration as a diagnostic and therapeutic measure in hypercalcemia including an assessment of the calcium-lowering effect of porcine calcitonin.
Andersen M
Acta Med Scand; 1972 Oct; 192(4):347-51. PubMed ID: 5081074
[No Abstract] [Full Text] [Related]
54. [Hypercalcemia in the elderly].
Raymakers JA
Tijdschr Gerontol Geriatr; 1990 Feb; 21(1):11-6. PubMed ID: 2180140
[TBL] [Abstract][Full Text] [Related]
55. Cancer and hypercalcemia of malignancy: a change in focus.
Muggia F
Semin Oncol; 1991 Aug; 18(4 Suppl 5):1-2. PubMed ID: 1925623
[No Abstract] [Full Text] [Related]
56. Clinical manifestations of cancer-related hypercalcemia.
Bajorunas DR
Semin Oncol; 1990 Apr; 17(2 Suppl 5):16-25. PubMed ID: 2185549
[TBL] [Abstract][Full Text] [Related]
57. [Endocrinological examination of malignant tumors. Hypercalcemia in malignant tumors].
Abe K
Rinsho Byori; 1974 Oct; 22(10 Suppl):28. PubMed ID: 4475870
[No Abstract] [Full Text] [Related]
58. Palliative care. Physical symptoms II.
Hull FM
J Clin Pharm Ther; 1990 Dec; 15(6):463-7. PubMed ID: 1708395
[No Abstract] [Full Text] [Related]
59. Management of hypercalcemia secondary to malignancy.
Borja ER; Pugh RP
Mo Med; 1974 Jan; 71(1):19-22. PubMed ID: 4273915
[No Abstract] [Full Text] [Related]
60. Management of disorders of calcium homoeostasis.
Rizzoli R; Bonjour JP
Baillieres Clin Endocrinol Metab; 1992 Jan; 6(1):129-42. PubMed ID: 1739391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
